Donald Munoz
Director of Finance/CFO at NUCANA PLC
Net worth: 40 238 $ as of 31/03/2024
Profile
Donald Munoz is currently the Director at Enterin, Inc., Chief Financial Officer at NOXXON Pharma, Inc., and Chief Financial Officer at NuCana Plc.
Previously, he worked as the Managing Director at Cowen & Co. LLC, Cowen Group, Inc., and Leerink Partners LLC.
He was also the Head-Investment Banking at Summer Street Research Partners.
Additionally, he served as the Chief Financial Officer at NOXXON Pharma AG and Group Chief Financial Officer at NOXXON Pharma NV Niederlassung Deutschland.
Munoz received his undergraduate degree from Dartmouth College and his MBA from Columbia Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NUCANA PLC
0.49% | 31/12/2023 | 154,760 ( 0.49% ) | 40 238 $ | 31/03/2024 |
Donald Munoz active positions
Companies | Position | Start |
---|---|---|
NUCANA PLC | Director of Finance/CFO | 01/10/2015 |
NOXXON Pharma, Inc. | Director of Finance/CFO | 23/09/2014 |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Director/Board Member | 07/04/2021 |
Former positions of Donald Munoz
Companies | Position | End |
---|---|---|
NOXXON Pharma NV Niederlassung Deutschland
NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Director of Finance/CFO | 01/09/2015 |
Summer Street Research Partners
Summer Street Research Partners Investment Banks/BrokersFinance Founded in 2002, Summer Street Research Partners is an investment banking and securities firm headquartered in Boston, Massachusetts. The firm is a subsidiary of Northland Securities, Inc. and their ultimate parent is Northland Capital Holdings, Inc. They were formerly known as Custom Equity Research, Inc. Summer Street Research firm focuses on the healthcare sector. | Corporate Officer/Principal | 01/09/2014 |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Director of Finance/CFO | 01/01/2014 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Corporate Officer/Principal | 01/01/2011 |
Cowen Group, Inc. /Old/
Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Cowen Group, Inc. provides investment banking for small to midsized companies in the alternative energy, consumer health care, media, technology, and telecommunications industries. It offers mergers and acquisitions advice, securities underwriting, equity offerings, private equity placements, and market-making. The company was founded in 1918 and is headquartered in New York, NY. | Corporate Officer/Principal | 04/11/2009 |
Training of Donald Munoz
Dartmouth College | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NUCANA PLC | Health Technology |
Private companies | 8 |
---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Summer Street Research Partners
Summer Street Research Partners Investment Banks/BrokersFinance Founded in 2002, Summer Street Research Partners is an investment banking and securities firm headquartered in Boston, Massachusetts. The firm is a subsidiary of Northland Securities, Inc. and their ultimate parent is Northland Capital Holdings, Inc. They were formerly known as Custom Equity Research, Inc. Summer Street Research firm focuses on the healthcare sector. | Finance |
Cowen Group, Inc. /Old/
Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Cowen Group, Inc. provides investment banking for small to midsized companies in the alternative energy, consumer health care, media, technology, and telecommunications industries. It offers mergers and acquisitions advice, securities underwriting, equity offerings, private equity placements, and market-making. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
NOXXON Pharma, Inc. | |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
NOXXON Pharma NV Niederlassung Deutschland
NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Donald Munoz